← Evidence map

ArticleThoracic cancer2023

Clinical significance of DNA damage response mutations in stage I and stage IIIa NSCLC.

Haoran Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2023
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 37704455